Beyond tissue concentrations

Antifungal penetration at the site of infection

Yanan Zhao, Brendan Prideaux, Shane Baistrocchi, Donald C. Sheppard, David S. Perlin

Research output: Contribution to journalReview article

Abstract

Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.

Original languageEnglish (US)
Pages (from-to)S161-S167
JournalMedical Mycology
Volume57
DOIs
StatePublished - Apr 1 2019
Externally publishedYes

Fingerprint

Infection
Pharmaceutical Preparations
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Morbidity
Mortality
Therapeutics

Keywords

  • antifungals
  • drug quantification
  • MALDI imaging
  • posaconazole
  • site of infection
  • tissue penetration

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Beyond tissue concentrations : Antifungal penetration at the site of infection. / Zhao, Yanan; Prideaux, Brendan; Baistrocchi, Shane; Sheppard, Donald C.; Perlin, David S.

In: Medical Mycology, Vol. 57, 01.04.2019, p. S161-S167.

Research output: Contribution to journalReview article

Zhao, Yanan ; Prideaux, Brendan ; Baistrocchi, Shane ; Sheppard, Donald C. ; Perlin, David S. / Beyond tissue concentrations : Antifungal penetration at the site of infection. In: Medical Mycology. 2019 ; Vol. 57. pp. S161-S167.
@article{3402d5c901e14711a0bbd25b6128f866,
title = "Beyond tissue concentrations: Antifungal penetration at the site of infection",
abstract = "Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.",
keywords = "antifungals, drug quantification, MALDI imaging, posaconazole, site of infection, tissue penetration",
author = "Yanan Zhao and Brendan Prideaux and Shane Baistrocchi and Sheppard, {Donald C.} and Perlin, {David S.}",
year = "2019",
month = "4",
day = "1",
doi = "10.1093/mmy/myy067",
language = "English (US)",
volume = "57",
pages = "S161--S167",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Beyond tissue concentrations

T2 - Antifungal penetration at the site of infection

AU - Zhao, Yanan

AU - Prideaux, Brendan

AU - Baistrocchi, Shane

AU - Sheppard, Donald C.

AU - Perlin, David S.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.

AB - Despite advances in antifungal therapy, invasive fungal infections remain a significant cause of morbidity and mortality worldwide. One important factor contributing to the relative ineffectiveness of existing antifungal drugs is insufficient drug exposure at the site of infection. Despite the importance of this aspect of antifungal therapy, we generally lack a full appreciation of how antifungal drugs distribute, penetrate, and interact with their target organisms in different tissue subcompartments. A better understanding of drug distribution will be critical to guide appropriate use of currently available antifungal drugs, as well as to aid development of new agents. Herein we briefly review current perspectives of antifungal drug exposure at the site of infection and describe a new technique, matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging, which has the potential to greatly expand our understanding of drug penetration.

KW - antifungals

KW - drug quantification

KW - MALDI imaging

KW - posaconazole

KW - site of infection

KW - tissue penetration

UR - http://www.scopus.com/inward/record.url?scp=85063808079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063808079&partnerID=8YFLogxK

U2 - 10.1093/mmy/myy067

DO - 10.1093/mmy/myy067

M3 - Review article

VL - 57

SP - S161-S167

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

ER -